← FDA DRUG APPROVALS
FDA NDA · NDA219990
GWYN LO
norelgestromin and ethinyl estradiol
Sponsor: VIATRIS SPECIALTY
APPLICATION
NDA219990
TYPE
NDA
ORIGINAL APPROVAL
2026-07-28
LATEST ACTION
2026-07-28
ROUTE
TRANSDERMAL
DOSAGE FORM
TRANSDERMAL SYSTEM
MARKETING STATUS
Prescription
Products
GWYN LOPrescription
TRANSDERMAL SYSTEM
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.